Top 10 Billionaire Stocks From 10 Billionaires
Why should we pay attention to billionaires’ stock picks? The answer has always been hidden in plain sight.
Horizon Therapeutics Public Ltd Co (HZNP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 7,000,000 | $763,980,000 | 11.32% | |
| 2. | Pentwater Capital Management Matthew Halbower | 6,100,000 | $665,754,000 | +73% | 6.44% |
| 3. | Farallon Capital Thomas Steyer | 5,419,823 | $591,519,482 | 3.34% | |
| 4. | Citadel Investment Group Ken Griffin | 3,978,009 | $434,159,902 | +215% | 0.09% |
| 5. | Soros Fund Management George Soros | 3,291,801 | $359,267,161 | +16% | 5.53% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.67 | 745 | Officer | 745 | 2022-08-04 | Filing | |
| $9.48 | 10,000 | Director | 25,448 | 2017-05-10 | Filing | |
| $31.32 | 10,000 | Director | 10,000 | 2015-08-19 | Filing | |
| $9.76 | 6,000 | Director | 6,000 | 2014-08-14 | Filing | |
| $6.50 | 32,075 | Director | 178,406 | 2013-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $113.03 | 27,129 | Officer | 56,338 | 2023-01-17 | Filing | |
| $113.17 | 36,148 | Officer | 277 | 2023-01-13 | Filing | |
| $113.10 | 3,368 | Officer | 36,171 | 2023-01-11 | Filing | |
| $113.05 | 3,368 | Officer | 39,539 | 2023-01-10 | Filing | |
| $113.29 | 5,187 | Officer | 49,314 | 2023-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 21,553,233 | $2,352,319,850 | 0.05% | |
| 2. | 14,934,488 | $1,629,949,992 | 0.04% | |
| 3. | 5,121,833 | $558,997,062 | 0.03% | |
| 4. | 3,179,053 | $346,483,560 | 0.04% | |
| 5. | 2,967,084 | $323,827,548 | 0.37% |
News See All
Billionaire John Paulson's 2023 Portfolio: Top 5 Stock Picks
In this article, we discuss the top 5 stock picks from John Paulson's latest portfolio.
5 Best Stocks to Buy According to Billionaire Paul Tudor Jones
In this piece, we will take a look at the five best stocks to buy according to billionaire Paul Tudor Jones.
Aristotle Atlantic Focus Growth Sold Horizon Therapeutics Public Limited Company (HZNP) on Acquisition News
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Horizon Therapeutics Public Limited Company (HZNP) Rose in Q4 on Acquisition News
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Should You Invest in Horizon Therapeutics Public Limited Company (HZNP)?
Renaissance Investment Management, an investment management company, released its “Midcap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
Horizon Therapeutics Public Limited Company (HZNP) Shares Got Re-Rated Due to Acquisition Announcement
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Hedge Fund and Insider Trading News: David Einhorn, Stan Druckenmiller, Ray Dalio, Paul Tudor Jones, George Soros, Modulo Capital, Altisource Portfolio Solutions S.A. (ASPS), Moderna, Inc. (MRNA), and More
David Einhorn, Founder and President of Greenlight Capital exited his stakes in Intel (INTC), Rivian Automotive (RIVN), and News Corp. (NWS) in Q4, according to the hedge fund’s 13-F filing.
George Soros' Top 5 Holdings
In this article, we will look at the top 5 holdings of billionaire investor George Soros.
Here's Why Horizon Therapeutics Public Limited Company (HZNP) Surged in Q4
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
